AI tool for doctors: help or hindrance? new study investigates

NCT ID NCT07401979

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at how different features of an AI system affect the way primary care doctors diagnose and treat respiratory infections. About 3,000 doctors in China will use a web-based tool with various AI features, such as automated data entry or stepwise medication suggestions. Researchers will measure whether the AI helps correct mistakes or leads doctors astray, aiming to design better AI support for clinical decisions.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
AI-based Clinical Decision Support System (AI-CDSS) with various features like automated data extraction and stepwise medication suggestions
What this could lead to
If successful, this could help design AI tools that better assist doctors in diagnosing and treating respiratory infections, potentially reducing antibiotic misuse.
What could go wrong
This is an early-stage observational study using simulated cases, not real patients. Results may not translate to actual clinical practice, and the AI might sometimes mislead doctors.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RESPIRATORY TRACT INFECTIONS (RTI) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Tongji Medical College of Huazhong University of Science & Technology School of Medicine and Health Management

    Wuhan, Hubei, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.